(Q34121232)

English

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

E Bria

7

0 references

Alex Molassiotis

object named as

A Molassiotis

16

0 references

1 reference

ORCID Public Data File 2021

author name string

F Roila

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

J Herrstedt

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

M Aapro

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

R J Gralla

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

L H Einhorn

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

E Ballatori

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

R A Clark-Snow

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

B T Espersen

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

P Feyer

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

S M Grunberg

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

P J Hesketh

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

K Jordan

13

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

M G Kris

14

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

E Maranzano

15

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

G Morrow

17

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

I Olver

18

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

B L Rapoport

19

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

C Rittenberg

20

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

M Saito

21

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

M Tonato

22

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

D Warr

23

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ESMO/MASCC Guidelines Working Group

24

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

21 Suppl 5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

v232-43

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

Potential role of the NK1 receptor antagonists in chemotherapy-induced nausea and vomiting

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 St

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

Randomized, double-blind, dose-ranging trial of the oral neurokinin-1 receptor antagonist casopitant mesylate for the prevention of cisplatin-induced nausea and vomiting.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

Fosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours following highly emetogenic chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

Electroacupuncture for refractory acute emesis caused by chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

Efficacy of aprepitant in patients receiving high-dose chemotherapy with hematopoietic stem cell support.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ194

21 January 2018

Identifiers

10.1093/ANNONC/MDQ194

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34121232&oldid=2104798080"